CDC panel recommends Pfizer maternal RSV vaccine to protect babies

By Gabrielle M. Etzel
Published September 22, 2023 8:06pm ET
Add Washington Examiner on Google
CDC panel recommends Pfizer maternal RSV vaccine to protect babies
An independent panel of independent advisers for the Centers for Disease Control and Prevention backed Pfizer’s respiratory syncytial virus, or RSV, vaccine for pregnant women to confer immunity to newborns on Friday. The panel recommended that pregnant women between 32 and 36 weeks gestation during cold and flu season take the RSV vaccine that was […]

An independent panel of independent advisers for the Centers for Disease Control and Prevention backed Pfizer’s respiratory syncytial virus, or RSV, vaccine for pregnant women to confer immunity to newborns on Friday.

Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

Centers for Disease Control and Prevention Health Mandy Cohen Vaccines